自体脂肪移植用于乳房再造的肿瘤学安全性
该回顾性、基于人群的队列研究利用2001至2018年去标识化理赔数据,纳入乳腺切除术后接受乳房再造的乳腺癌患者,比较脂肪移植组与未移植组的转移和死亡情况。倾向性评分匹配后,脂肪移植与淋巴结转移、远处转移及全因死亡率升高均无显著关联。
要点
- 倾向性评分匹配后,脂肪移植组淋巴结转移9.7% vs 非脂肪移植组11.4%(P=0.47)。
- 远处转移脂肪移植组9.1% vs 非脂肪移植组10.5%(P=0.53)。
- 全因死亡脂肪移植组3.9% vs 非脂肪移植组6.6%(P=0.10)。
核心结论
- 在随后接受脂肪移植的乳腺癌患者中,与非脂肪移植相比,远处转移或全因死亡率未见显著增加。
- 这些发现提示肿瘤切除和再造后的自体脂肪移植与未来转移或死亡风险增加无关。
研究设计与样本
- 回顾性、基于人群的队列研究,使用2001至2018年去标识化理赔数据。
- 纳入乳腺切除术后接受乳房再造的私人保险乳腺癌患者。
- 共识别4709例接受肿块切除或乳房切除后乳房再造的患者,其中368例随后接受脂肪移植。
- 采用一对一倾向性评分匹配以控制患者危险因素的选择偏倚。
- 评估再造后长达15年的转移和死亡。
主要发现
- 倾向性评分匹配患者中,脂肪移植与淋巴结转移风险增加无关(脂肪移植组9.7% vs 非脂肪移植组11.4%,P=0.47)。
- 脂肪移植与远处转移风险增加无关(脂肪移植组9.1% vs 非脂肪移植组10.5%,P=0.53)。
- 乳房再造后脂肪移植的全因死亡率未见增加(脂肪移植组3.9% vs 非脂肪移植组6.6%,P=0.10)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous fat grafting has become a vital component of breast reconstruction. However, concerns remain regarding the safety of fat grafting after oncological resection and breast reconstruction. The purpose of the study was to evaluate the association of fat grafting after breast reconstruction with metastasis and death in breast cancer patients. METHODS: A retrospective, population-based cohort study was conducted using deidentified claims data from 2001 to 2018 and included privately insured patients with breast cancer who underwent breast reconstruction after surgical resection. Breast reconstruction patients who underwent fat grafting were compared with those not undergoing fat grafting, evaluating metastasis and death up to 15 years after reconstruction. One-to-one propensity score matching was used to account for selection bias on patient risk factors comparing those with and without fat grafting. RESULTS: A total of 4709 patients were identified who underwent breast reconstruction after lumpectomy or mastectomy, of which 368 subsequently underwent fat grafting. In the propensity score-matched patients, fat grafting was not associated with an increased risk of lymph node metastasis (9.7% fat-grafted vs 11.4% in non-fat-grafted, P = 0.47) or distant metastasis (9.1% fat-grafted vs 10.5% in non-fat-grafted, P = 0.53). There was no increased risk of all-cause mortality after fat grafting for breast reconstruction (3.9% fat-grafted vs 6.6% non-fat-grafted, P = 0.10). CONCLUSIONS: Among breast cancer patients who subsequently underwent fat grafting, compared with no fat grafting, no significant increase was observed in distant metastasis or all-cause mortality. These findings suggest that autologous fat grafting after oncologic resection and reconstruction was not associated with an increased risk of future metastasis or death.
引用
- Strong AL, Syrjamaki JD, Kamdar N, et al. Oncological Safety of Autologous Fat Grafting for Breast Reconstruction. Ann Plast Surg. 2024. PMID: 38117044. doi:10.1097/SAP.0000000000003772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。